Reducing lung transplant rejection aim of clinical trial funded with $22 million grant
Scienmag
NOVEMBER 18, 2021
Physicians at Washington University School of Medicine in St.
86 
Pfizer’s Paxlovid Ineffective Against Long COVID Using 15-Day Regimen: Study
BioSpace
JUNE 10, 2024
While a prolonged, 15-day regimen of Paxlovid is safe, it appears to be ineffective at lowering the symptoms of long COVID, according to results of a Phase II trial funded by Pfizer and conducted by Stanford Medicine.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Government of Canada invests in clinical trial development in Canada through the Clinical Trials Fund
Pharma in Brief
JUNE 26, 2022
On June 22, 2022, the Canadian Institutes of Health Research ( CIHR ) announced the launch of the Clinical Trials Fund ( CTF ), which will inject funding into Canada’s clinical trials environment. The Clinical Trials Fund.
Oral immunotherapy induces remission of peanut allergy in some young children
Scienmag
JANUARY 20, 2022
A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5
Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy
pharmaphorum
SEPTEMBER 16, 2020
Adding Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib) and Gilead Sciences’ remdesivir reduces recovery time in COVID-19 patients compared to remdesivir alone, says a new trial. For now, analysis of the safety and mortality data from ACTT-2 are still ongoing, according to the president of Lilly Bio-Medicines, Patrik Jonsson.
NIH expands clinical trials to test convalescent plasma against COVID-19
Scienmag
SEPTEMBER 22, 2020
Rigorous studies to build on earlier efforts to test the experimental treatment Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19.
New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue
The Pharma Data
JANUARY 15, 2021
15, 2021 — An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds. 13 in the New England Journal of Medicine , involved patients with high blood pressure in the lungs caused by interstitial lung disease (ILD). FRIDAY, Jan.
Let's personalize your content